9.00 – 10.30

REGISTRATION (Hall: Foyer 2)

TOP WORKSHOP ON SUBSTITUTION TREATMENT

Hall: E1

10.00 - 13.00

METHADONE

Robert Newman (USA)

Andrej Kastelic (Slovenia)
Zvonka Dremelj (Slovenia): Urine tests

13.00

LUNCH (Only for the workshop participants)

13.30 – 15.30

REGISTRATION (Hall: Foyer 2)

TOP WORKSHOP ON SUBSTITUTION TREATMENT (Workshop and dinner are sponsored by Schering Plough)

Hall: Kosovel

15.00 – 18.00

SUBOXONE

Johan Kakko (Sweden): Methadone assisted treatment vs. a stepped strategy utilizing buprenorphine and methadone:

Results of the Swedish 3G study (69)

Erik Gunderson (USA): Buprenorphine-naloxone as part of general medical practice: the US experience (76)

James Bell (UK): Australian trials of buprenorphine-naloxone (61)

Andrej Kastelic (Slovenia): The Slovenian experience with buprenorphine

18.30

DINNER

8.30 – 10.00

REGISTRATION (Hall: Foyer 2)

TOP WORKSHOP ON SUBSTITUTION TREATMENT

Hall: Kosovel

9.30 – 11.00

Robert Haemmig (Switzerland): Heroin prescription in Switzerland: heroin assisted treatment helps to better understand opioids (Practice

and Results) (67)

Peter Hofmann (Austria): Naltrexone (Presentation is sponsored by Torrex – Chiesi)

11.00 – 11.30

BREAK

TOP WORKSHOP ON SUBSTITUTION TREATMENT (Workshop is sponsored by Medis)

11.30 – 13.30

SR MORPHINE

Gabriele Fisher (Austria)

Goran Dubajić (Slovenia)

Jasna Čuk Rupnik (Slovenia)

13.30

LUNCH (Only for the workshop participants)

12.00 - 20.00

REGISTRATION (Hall: Foyer 2)

15.00 – 16.30

PLENNARY SESSION

Hall: Kosovel

Chairs: Gabriele Fisher, Mark Parrino

Robert Newman (USA): Development of ST

Sebastian Saville (UK): International Drug Policy Consortium

Lars Moller (WHO): Health in prisons and ST (54)

Gabriele Fisher (Austria): Women and ST

James Bell (UK): Specialty recognition of addiction medicine in Australia (16)

16.30 – 17.00

BREAK

17.00 – 18.45

OPENING PLENNARY

Hall: Kosovel

Chairs: Annette Verster, Andrej Kastelic

Fabienne Hariga (UNODC): UNODC policy and access to ST

Annette Verster (WHO): Evidence for ST treatment

Stijn Goossens (INPUD): The role of INPUD

Mark Parrino (USA): The role of AATOD

Icro Maremmani (Italy): The role of EUROPAD

19.00 – 20.00

OPENING CEREMONY:

The conference will be opened by Lord Mayor of Ljubljana, ZORAN JANKOVIČ

Hall: Kosovel

Icro Maremmani, EUROPAD

Mark Parrino, AATOD

Fabienne Hariga, UNODC

Annette Verster, WHO

Robert Newman, ICAAT

Andrej Kastelic, SEEA net

MOJCA HORVAT YOUTH DANCE COMPANY: CHILDREN FROM THE STATION ZOO - FRAGMENTS

20.00 – 22.00

WELCOME RECEPTION

8.00 - 20.00

REGISTRATION (Hall: Foyer 2)

9.00 - 11.00

PLENNARY SESSION I

Hall: Štih

Chairs: Irina Grishayeva, Icro Maremmani

Raminta Stuikyte, Genci Mucollari (CEEHRN): Substitution treatment in Central-Eastern Europe and Central Asia (57)

Milena Naydenova (Bulgaria): Substitution treatment (17)

Irina Grishayeva, Gundo Weiler (Ukraine): Substitution therapy scale-up in Ukraine – multi- dimensional approach (42)

Luis Patricio (Portugal): Development of opiate addiction treatment in Portugal

James Bell (UK): What does pharmacology have to do with treatment? (60)

11.00 – 11.30

BREAK

11.30 – 13.30

SPECIAL INTEREST SESSION

Hall: Štih

SPECIAL INTEREST SESSION

Hall: E1

ST IN PRIMARY HEALTH CARE SETTINGS

Chairs: Ante Ivančić , Jasna Čuk Rupnik

RESEARCH

Chair: Vera Grebenc, Georgi Vasilev

Ante Ivančić (Croatia): Treatment of Opioid Dependence in Primary Health Care (63)

Marc Reisinger (Belgium): Office based ST

Stephan Walcher (Germany): Primary care settings (78)

Hrvoje Tiljak (Croatia): Methadone to buprenorphine and

buprenorphine to methadone in primary health care – Croatian experience (47)

Nardo Stegelj (Slovenia): ST in private practice in Slovenia

Albrecht Ulmer (Germany): Dihydrocodeine: A new option for

alcohol addicts (5)

Sergiy Dvoryak (Ukraine): European aspects of the who collaborative study on substitution therapy of opioid dependence and HIV/AIDS (58)

Franz Trautman (The Netherlands), Nino Rode (Slovenia):

Evaluation of the methadone maintenance programmes in Slovenia (50)

Alfred Uhl, Alfred Springer (Austria): Substitution treatment in Austria (27)

Vera Grebenc, Ines Kvaternik (Slovenia): Researching needs in the community - drug users as partners in research process (30)

M . Jovanović (Serbia): Neuroimaging techniques such as CT and mini mental scale of long-term opiate addicts (66)

13.30 – 14.30

LUNCH

SEEA NET ORGANISATIONAL MEETING (13.45 – 14.30);

Hall: E1

All participants from SEEA region and others as well, are welcome.

14.30 – 16.30

PARALLEL PLENNARY SESSION II

Hall: Štih

Chair: Ernst Buning

PARALLEL PLENNARY SESSION III

Hall: E1

Chair: Lubomír Okruhlica

Vito Flaker (Slovenia): ST in Everyday Life

Icro Maremmani (Italy): Patient with comorbidity in ST

Mario Sanches (France): ST in France (70)

Peter Vossenberg (The Netherlands): RIOB: Dutch guideline on opiate maintenance treatment (51)

Vitomir Georgievski (Macedonia): Me, my addiction and the influenze

of substitution therapy (41)

Tatjana Stamatović, Dušan Mihajlović (Serbia): Substitution therapy - the Belgrade experience (38)

Martin Blakebrough (UK): Pharmacy dispensing versus community

Stephan Walcher (Germany): ST interactions (79)

Lubomír Okruhlica, (Slovac Republic): How to cope with methamphetamine epidemics in MMTP (25)

Stijn Goossens (INPUD): Medical assisted treatment of dependency. What about cocaine, amphetamine type stimulants (ATS)? (19)

Albrecht Ulmer (Germany): Dihydrocodeine: Another important substance for opiate addicts (6)

16.30 – 17.00

BREAK

17.00 – 18.45

SPECIAL INTEREST SESSIONS

PRISONS

Hall: Štih

Chair: Holly Catania

POLICY - DIFFERENT PRACTICES

Hall: E1

Chair: Nora Stojanovik, Ante Ivančić

Lars Moller (WHO): Health in prisons – a WHO guide to the essentials

in prison health (New publication from the WHO regional office for Europe) (54)

Fabienne Hariga (UNODC): Framework for HIV AIDS prevention in prisons

Olga Perhavc (Slovenia): Drug addiction treatment in Slovenian

prisons

Dragan Milkov (Serbia): Center for treatment and prevention of drug addiction in Novi Sad county prison (62)

Hoellmueller Huber (Austria): Behavioural paradigms of social care workers in the work with drug addicted persons in alternative

settings (52)

Irina Grishayeva, Gundo Weiler (Ukraine): Preparing

personnel for OST scale-up in Ukraine: adapting the World Health Organization opioid substitution training programme and updating the national OST methadone protocol (43)

Georgi Vasilev (Bulgaria): Working together – day TC and methadone maintenance program (77)

Milazim Gjocaj (Kosovo): Kosovo drugs law, strategy and

policy (20)

Jože Hren (Slovenia): Contribution to the development of drug demand services in Slovenia (29)

Genci Mucollary (Albania): ST in Albania

18.45-19.00

BREAK

19.00

INAUGURAL MEETING – WORLD FEDERATION OF THE ASSOCIATIONS FOR THE TREATMENT OF OPIOID DEPENDENCE

Hall: Štih

Ernst Buning (The Netherlands): Euromethwork: mission complete?(53)

Pat O’Hare (IHRA)

Mark Parrino (AATOD)

Icro Maremmani (EUROPAD)

Andrej Kastelic (SEEA net)

20.30

WFATOD RECEPTION

8.00 – 16.00

REGISTRATION (Hall: Foyer 2)

9.00-10.30

SPECIAL INTEREST SESSIONS

OVERDOSE AND ST

Hall: Štih

Chair: Mauro Guarinieri (IHRD)

SEEA NET

Hall: E1

Chair: Nermana Mehić-Basara

Mauro Guarinieri (IHRD): Overdose prevention (65)

Catania Holly (USA): Overdose prevention (72)

Stephan Walcher (Germany): Drug Substitution Emergencies (80)

Eric Schneider (France): From low and high threshold to adapted threshold (1)

Majda Zorec Karlovšek (Slovenia): The forensic aspects of opiate dependence (59)

Mehić-Basara N., Cerić I., Grabovica M. (Bosnia and Herzegovina): Methadone and illicit drugs abuse during the methadone maintenance program (49)

Liljana Ignjatova (Macedonia). Self initiative interruptions of the take home methadone doses are a risk factor for the treatment outcome (2)

Danijela Budiša (Serbia): Algorithm and models of drug addicts’ treatment in Novi Sad (28)

A.M. Caran, G. Dubajić, A. Kastelic: Opioid dependence treatment with buprenorphine: a 2-year experience from four Slovenian Slovenian Centers for Prevention and Treatment of Drug Addictions (48)

Mihai Tanasescu (Romania): Substitution treatment in Romania (75)

10.30– 11.00

BREAK

11.00 – 13.00

SPECIAL INTEREST SESSIONS

HEPATITIS C and ST

Hall: Štih

Chair: Mojca Matičič

TREATMENT

Hall: E1

Chair: Mojca Hvala Cerkovnik

Mojca Matičič (Slovenia): Management of hepatitis C virus

infection in drug users: Slovenian experiences and national guidelines (55)

Mauro Guarinieri (IHRD): Prevention of hepatitis C (64)

Simona Merkinaite, Nora Stojanovik (CEEHRN): Hepatitis C among drug users in the new EU member states and neighborhood (56)

Milena Naydenova (Bulgaria): Advocacy for treating HCV (37)

Vratislav Rehak, Laura Krekulova: Hepatitis C antiviral treatment is highly effective in the drug users in the Czech Republic (71)

M.Karagjozova (Macedonia). Risk behavior and a hepatitis C infection at patients in a methadone maintenance therapy in service of prevention and treatment of drug abuse in Tetovo (4)

Alexander Kantchelov (Bulgaria): Comprehensive treatment for heroin addiction: what and why (73)

Rachel Chernick (USA): The Rewards and Challenges of Providing Integrated Services in Methadone Maintenance Treatment (3)

Ernst Nagelschmied, Michaela Koncila (Austria): Drug-counselling service (municipality of Klagenfurt) (11)

Silvia Slezáková, Ľubomír Okruhlica, (Slovac Republic): Weight gain in patients during methadone maintenance treatment and compare with the population (21)

Katja Dular, Velikonja Globevnik Vislava (Slovenia): Pregnancy and drug addiction (31)

Jasna Čuk Rupnik (Slovenia): Can our clients be good parents? (39)

13.00 – 14.00

LUNCH

13.15 – 14.00 WORKSHOP; Hall: E1

Tatjana Oprešnik Rodman, Branko Bregar, Rezka Horvat, Mojca Hvala

Cerkovnik, Mateja Okanovič, Vesna Mejak (Slovenia): Presentation of the Center for treatment of drug addiction, Ljubljana, Slovenia (68)

14.00 – 15.00

STATUS OF TREATMENT PROVIDERS (ROUND TABLE)

Hall: Štih

INPUD meeting

Hall: E5

Marc Reisinger (Belgium), Holly Catania (USA): Role of the

treatment providers and legal issues of ST

ROUND TABLE DISCUSSION

James Bell (UK)

Jasna Čuk Rupnik (Slovenia)

Ante Ivančić (Croatia)

Alexander Kantchelov (Bulgaria)
Icro Maremmani (Italy)

Genci Mucollari (Albania)

Marc Parrino (USA)

15.00

CLOSING

16.00 – 18.00

SITE VISIT (Please register at the Reception desk until Tuesday, 12.00)

· National Centre for Treatment of Drug Addicts (Zaloska 29, Ljubljana)

· Center for Prevention and Treatment of Drug Addiction Ljubljana (Metelkova 9, Ljubljana)

GUIDED SIGHT SEEING TOUR OF LJUBLJANA (Please register at the reception desk)

Monday, 11.00 - 13.00

Tuesday, 15.30

1

Aneta Spasovska Trajanovska, Zora Mitic, Lilijana Ignjatova

R. Macedonia

EFFECTIVENESS OF SERTRALINE IN TREATMENT OF DEPRESSIVE DISORDERS IN METHADONE MAINTENANCE PATIENTS

2

Aneta Spasovska Trajanovska, Olivera Subotin Popovska

R. Macedonia

ASCORBIC ACID (VITAMIN C) EFFECTS ON WITHDRAWAL SYNDROME OF HEROIN ABUSERS

3

Aneta Spasovska Trajanovska, Olivera Subotin Popovska

R. Macedonia

EFFECTIVENESS BETWEEN SERTRALINE AND PAROXETINE IN REDUCE OPIOID USE AND DEPRESSIVE SYMTOMS ON EARLY ABSTINENCE FROM OPIOID DRUGS(HEROIN)

4

Olivera Subotin Popovska, Aneta Spasovska Trajanovska

R. Macedonia

EFFECTIVENESS OF RISPERIDONE ON WITHDRAWAL SYNDROME OF HEROIN USERS

5

Milkovska Stojna

R. Macedonia

CHARACTERISTIC OF THE FAMILIES OF ADDICTIVE PERSONS INCLUDED IN METHADONE PROGRAM ON DAILY CENTER FOR ADDICTIONS- KUMANOVO, REPUBLIC OF MACEDONIA

6

Roza ARSOVA, Marija KARAGOZOVA, Nade ALEKSOVA, Vesna PANEVA, Vesna ILIEVA, Kina PANZOVA

Republic of Macedonia

INFORMATION AND RISK BEHAVIOR OF THE MEMBERS OF FAMILIES WITH PERSONS WITH CHRONIC HEPATITIS

7

Mirjana Savevska,

Macedonia

BENEFICIAL EFFECTS OF FAMILY THERAPY OF DRUG ADDICTION AFTER THE TREATMENT (IN THE PERIOD OF ABSTINENCE)

8

Csorba József, Barta Csaba, Szilágyi Ágnes, Sasvári-Székely Mária, Balázs, Hedvig, Hoffmann Katalin, Demetrovics Zsolt

Hungary

A FOLLOW-UP EVALUATION OF METHADONE MAINTENANCE THERAPY IN HUNGARY: IS EFFECTIVENESS INDEPENDENT OF THE LENGTH OF TREATMENT?

9

Csorba J1, Szilagyi A2, Sasvari-Szekely M2, Hoffmann K3, Demetrovics Z3 and Barta C2

Hungary

RESPONSE TO METHADONE THERAPY OF HEROIN DEPENDENT PATIENTS IS INFLUENCED BY GENETIC FACTORS

10

Lukasz Lapinski, Jacek Gasiorowski, Anna Wiela-Hojenska, Krystyna Glowacka, Brygida Knysz, Krystyna Orzechowska-Juzwenko, Andrzej Gladysz

Poland

IS ABCB1 GENOTYPE POLYMORPHISM A RISK FACTOR IN THE DEVELOPMENT OF OPIOID DEPENDENCE?

11

Jacek Gasiorowski, Lukasz Lapinski, Anna Wiela-Hojenska, Brygida Knysz, Krystyna Glowacka, Krystyna Orzechowska-Juzwenko, Andrzej Gladysz¹

Poland

INFLUENCE ABCB1 GENE POLYMORPHISM ON METHADONE DOSE AND PLASMA CONCENTRATION IN OPIOID SUBSTITUTION TREATMENT

12

Jasna Čuk Rupnik

Katarina Hodnik

Slovenia

WHAT OUR CLIENTS THINK ABOUT OUR WORK

13

Garriga Ramon, T; Samper Villar

Spain

EVALUATION OF ASSISTENTIAL GOALS TO USERS IN PMM: RESEARCH ABOUT

QUALITY OF LIFE

14

Samper Villar, J. ; Garriga Ramon, T. ; Falip Centelles, C. ; Reyes, S.

Spain

PATIENTS DRUG ADDICTS WITH LIMIT DISORDER OF PERSONALITY: CLINIC TEST WITH RISPERIDONA THROUGH INTRAMUSCULAR

15

Muhamed Masic

Bosnia and Herzegovina

METHADONE PROGRAM USING JUNG DEPTH PSYCHOLOGY AND MINDFULNESS APPROACH

16

Ilonka Vučko Miklavčič, Peter Pregelj

Slovenia

PSYHOSIS RELATED TO CANNABIS USE